Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Instructions for Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Instructions for Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
rheumatology
Email alerts
rheumatology
COVID-19 vaccination and immunomodulatory or immunosuppressive drugs: indications and contraindications
Yashdeep Singh
Pathania
BMJ Supportive & Palliative Care
Oct 2021,
bmjspcare-2021-003371;
DOI:
10.1136/bmjspcare-2021-003371
Vulnerability of patients on immunosuppressive therapy to SARS-CoV-2 reinfection
Yashdeep Singh
Pathania
BMJ Supportive & Palliative Care
Jul 2021,
bmjspcare-2021-003260;
DOI:
10.1136/bmjspcare-2021-003260
CLINICAL
(8947)
NON-CLINICAL
(3136)
Special collections
Editor's choice
(26)
Guidelines, Recommendations and Consensus Statements
Open access
(114)
Press releases
(11)